{"id":65599,"date":"2026-05-18T23:24:53","date_gmt":"2026-05-18T15:24:53","guid":{"rendered":"https:\/\/flcube.com\/?p=65599"},"modified":"2026-05-18T23:24:54","modified_gmt":"2026-05-18T15:24:54","slug":"bms-partners-with-tigerlily-foundation-to-address-racial-disparities-in-breast-cancer-clinical-trial-access-pharma-giant-commits-to-improving-representation-of-young-women-of-color","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=65599","title":{"rendered":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color"},"content":{"rendered":"\n<p><strong>Bristol-Myers Squibb (BMS)<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/BMY:NYSE\">NYSE: BMY<\/a>) announced a strategic partnership with the <strong>Tigerlily Foundation<\/strong>, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly <strong>women of color<\/strong>. The collaboration aims to increase <strong>awareness, education, and engagement<\/strong> in clinical research among historically underrepresented populations in oncology trials.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-overview\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Bristol-Myers Squibb (NYSE: BMY) and Tigerlily Foundation<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>Week of May 12, 2026<\/td><\/tr><tr><td><strong>Focus Population<\/strong><\/td><td>Young women with breast cancer, particularly women of color<\/td><\/tr><tr><td><strong>Primary Objectives<\/strong><\/td><td>Clinical trial awareness, education, and engagement<\/td><\/tr><tr><td><strong>Strategic Alignment<\/strong><\/td><td>Shared commitment to health equity and representation in research<\/td><\/tr><tr><td><strong>Geographic Scope<\/strong><\/td><td>National (United States)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-health-equity-context-amp-unmet-need\">Health Equity Context &amp; Unmet Need<\/h2>\n\n\n\n<p><strong>Racial disparities in breast cancer outcomes<\/strong> remain stark despite advances in treatment:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Black women<\/strong> are <strong>40% more likely<\/strong> to die from breast cancer than white women<\/li>\n\n\n\n<li><strong>Hispanic and Asian women<\/strong> face significant barriers to clinical trial participation<\/li>\n\n\n\n<li><strong>Young women of color<\/strong> are consistently <strong>underrepresented<\/strong> in oncology clinical trials (&lt;5% enrollment despite higher incidence of aggressive subtypes)<\/li>\n\n\n\n<li><strong>Systemic barriers<\/strong> include lack of awareness, mistrust of medical research, geographic access limitations, and socioeconomic constraints<\/li>\n<\/ul>\n\n\n\n<p><strong>The Tigerlily Foundation&#8217;s mission<\/strong> directly addresses these gaps through:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Culturally competent education and outreach programs<\/li>\n\n\n\n<li>Patient navigation and support services<\/li>\n\n\n\n<li>Advocacy for policy changes improving access to care<\/li>\n\n\n\n<li>Community-based engagement initiatives targeting underserved populations<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-industry-context\">Strategic Rationale &amp; Industry Context<\/h2>\n\n\n\n<p>This partnership reflects broader <strong>pharmaceutical industry trends<\/strong> toward addressing diversity in clinical research:<\/p>\n\n\n\n<p><strong>Regulatory Pressure:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>FDA guidance emphasizing demographic diversity in clinical trial populations<\/li>\n\n\n\n<li>Increased scrutiny of trial design and recruitment practices<\/li>\n\n\n\n<li>Requirements for diversity action plans in certain therapeutic areas<\/li>\n<\/ul>\n\n\n\n<p><strong>Commercial Imperatives:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Recognition that diverse trial populations improve drug safety and efficacy data<\/li>\n\n\n\n<li>Enhanced market access through demonstrated real-world effectiveness across demographics<\/li>\n\n\n\n<li>Strengthened brand reputation and community trust<\/li>\n<\/ul>\n\n\n\n<p><strong>BMS&#8217;s Oncology Portfolio Relevance:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Extensive breast cancer pipeline including immunotherapies and targeted agents<\/li>\n\n\n\n<li>Existing marketed products requiring diverse post-marketing surveillance data<\/li>\n\n\n\n<li>Competitive positioning against peers with established health equity initiatives<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-program-components-amp-implementation\">Program Components &amp; Implementation<\/h2>\n\n\n\n<p>The collaboration will focus on three core pillars:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-awareness-campaigns\">Awareness Campaigns<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Culturally tailored educational materials about clinical trial benefits and processes<\/li>\n\n\n\n<li>Social media and digital outreach targeting young women of color<\/li>\n\n\n\n<li>Community events and town halls addressing historical mistrust of medical research<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-education-initiatives\">Education Initiatives<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Patient navigation programs to guide interested participants through trial enrollment<\/li>\n\n\n\n<li>Healthcare provider training on inclusive recruitment practices<\/li>\n\n\n\n<li>Resource development for community organizations supporting breast cancer patients<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-engagement-strategies\">Engagement Strategies<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Direct connection between interested patients and relevant BMS-sponsored trials<\/li>\n\n\n\n<li>Feedback mechanisms to continuously improve recruitment approaches<\/li>\n\n\n\n<li>Measurement and reporting of diversity metrics in BMS oncology trials<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competitive-landscape-amp-industry-leadership\">Competitive Landscape &amp; Industry Leadership<\/h2>\n\n\n\n<p><strong>Peer pharmaceutical companies<\/strong> have launched similar initiatives:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pfizer&#8217;s &#8220;Diversity Action Plan&#8221;<\/strong> targeting 30% minority enrollment in US trials by 2025<\/li>\n\n\n\n<li><strong>Merck&#8217;s partnerships<\/strong> with historically Black medical schools and community health centers<\/li>\n\n\n\n<li><strong>AstraZeneca&#8217;s &#8220;Health Equity Initiative&#8221;<\/strong> focusing on cancer screening and trial access<\/li>\n<\/ul>\n\n\n\n<p><strong>BMS&#8217;s partnership differentiates through:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Focus on <strong>young women specifically<\/strong>, addressing unique needs of this demographic<\/li>\n\n\n\n<li>Collaboration with <strong>established patient advocacy organization<\/strong> rather than academic institutions<\/li>\n\n\n\n<li><strong>Long-term commitment<\/strong> beyond single trial recruitment to systemic change<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Enhanced Trial Recruitment:<\/strong> Improved access to diverse patient populations for BMS oncology studies<\/li>\n\n\n\n<li><strong>Regulatory Preparedness:<\/strong> Proactive response to evolving FDA diversity requirements<\/li>\n\n\n\n<li><strong>Brand Reputation:<\/strong> Strengthened position as socially responsible healthcare partner<\/li>\n\n\n\n<li><strong>Pipeline Success:<\/strong> Better clinical data supporting approval and reimbursement across diverse populations<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding strategic partnerships, clinical trial recruitment, and diversity initiatives. Actual results may differ due to risks including implementation challenges, competitive dynamics, and regulatory developments.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[429,428,849],"class_list":["post-65599","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-bms","tag-bristol-myers-squibb","tag-nyse-bmy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=65599\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color\" \/>\n<meta property=\"og:description\" content=\"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=65599\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-18T15:24:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T15:24:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color\",\"datePublished\":\"2026-05-18T15:24:53+00:00\",\"dateModified\":\"2026-05-18T15:24:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599\"},\"wordCount\":610,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"BMS\",\"Bristol-Myers Squibb\",\"NYSE: BMY\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65599#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=65599\",\"name\":\"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-18T15:24:53+00:00\",\"dateModified\":\"2026-05-18T15:24:54+00:00\",\"description\":\"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65599\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65599#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color - Insight, China&#039;s Pharmaceutical Industry","description":"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=65599","og_locale":"en_US","og_type":"article","og_title":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color","og_description":"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.","og_url":"https:\/\/flcube.com\/?p=65599","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-18T15:24:53+00:00","article_modified_time":"2026-05-18T15:24:54+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=65599#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=65599"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color","datePublished":"2026-05-18T15:24:53+00:00","dateModified":"2026-05-18T15:24:54+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=65599"},"wordCount":610,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["BMS","Bristol-Myers Squibb","NYSE: BMY"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=65599#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=65599","url":"https:\/\/flcube.com\/?p=65599","name":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-18T15:24:53+00:00","dateModified":"2026-05-18T15:24:54+00:00","description":"Bristol-Myers Squibb (BMS) (NYSE: BMY) announced a strategic partnership with the Tigerlily Foundation, a leading national nonprofit dedicated to eliminating disparities in cancer care for young women, particularly women of color. The collaboration aims to increase awareness, education, and engagement in clinical research among historically underrepresented populations in oncology trials.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=65599#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=65599"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=65599#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"BMS Partners with Tigerlily Foundation to Address Racial Disparities in Breast Cancer Clinical Trial Access \u2013 Pharma Giant Commits to Improving Representation of Young Women of Color"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=65599"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65599\/revisions"}],"predecessor-version":[{"id":65600,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65599\/revisions\/65600"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=65599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=65599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=65599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}